Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Genpact Ltd shares valued at $606,560 were sold by Kalra Balkrishan on Dec 13 ’24. At $44.60 per share, Kalra Balkrishan sold 13,600 shares. The insider’s holdings dropped to 267,404 shares worth approximately $11.54 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, BALKRISHAN KALRA purchased 13,600 shares, netting a total of over 606,574 in proceeds.
Before that, Kalra Balkrishan had sold 9,000 shares from its account. In a trade valued at $417,600, the President and CEO traded Genpact Ltd shares for $46.40 each. Upon closing the transaction, the insider’s holdings decreased to 9,000 shares, worth approximately $11.54 million.
As published in a research note from JP Morgan on July 17, 2024, Genpact Ltd [G] has been rated up from an Underweight to a Neutral and the price target has been revised to $40 from $43. Analysts at Mizuho started covering the stock with ‘”a Neutral”‘ outlook in a report released in late January. As of December 15, 2023, Robert W. Baird has decreased its “an Outperform” rating to a “Neutral” for G. Earlier on August 22, 2023, JP Morgan downgraded its rating. Their new recommendation was “an Underweight” for G stock which previously was a “a Neutral”.
Analyzing G Stock Performance
During the last five days, there has been a surge of approximately 2.54%. Over the course of the year, Genpact Ltd shares have jumped approximately 24.29%. Shares of the company reached a 52-week high of $47.98 on 11/08/24 and a 52-week low of $30.23 on 04/18/24. A 50-day SMA is recorded $42.83, while a 200-day SMA reached $36.57. Nevertheless, trading volume fell to 0.64 million shares from 0.41 million shares the previous day.
Support And Resistance Levels for Genpact Ltd (G)
According to the 24-hour chart, there is a support level at 42.70, which, if violated, would cause prices to drop to 42.26. In the upper region, resistance lies at 43.43. The next price resistance is at 43.71. RSI (Relative Strength Index) is 45.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.77, which suggests the price will decrease in the coming days. Percent R is at 65.63%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
